Cellebrite Rg-A
CLBT
USD
STOCK MARKET:
NMS
Open
 
...
Large gap with delayed quotes
Last quote
09/03/2025 - 21:40:21
Bid
09/03/2025 - 21:40:33
Bid
Volume 		Ask
09/03/2025 - 21:40:33
Ask
Volume
16.53
+0.17 ( +1.04% )
16.52
300
16.54
900
More information
Analysis by TheScreener
02.09.2025
Evaluation Slightly negative  
Interest Weak  
Sensibility High  
Analysis date: 02.09.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 13.05.2025.
Interest
  Weak
Two stars since 19.08.2025.
Earnings Rev Trend
  -0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is negative since 15.07.2025 at a price of 14.25.
Evaluation
  Overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 15.08.2025.
4wk Rel Perf
  20.38%
 
The four-week dividend-adjusted overperformance versus Tel Aviv 125 Index is 20.38%.
Sensibility
  High
The stock has been on the high-sensitivity level since 25.02.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.91%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 4.12%.
Mkt Cap in $bn
  3.93
With a market capitalization between $2 & $8bn, CELLEBRITE DI is considered a mid-cap stock.
G/PE Ratio
  0.88
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  37.75
The estimated PE is for the year 2027.
LT Growth
  33.09%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  7
Over the last seven weeks, an average of 7 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  26
For 1% of index variation, the stock varies on average by 0.26%.
Correlation
  0.12
Stock movements are totally independent of index variations.
Value at Risk
  6.88
The value at risk is estimated at USD 6.88. The risk is therefore 42.04%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  25.02.2025